Do UK founders need a Delaware company to raise US investment?

Why does US capital exert such a pull on UK founders?

The US is the centre of gravity for startup capital, and its influence runs from the macro level down to the individual term sheet. In 2025 US companies raised roughly $274bn, close to 64% of all global venture funding [1], and US VC funds hold roughly €930bn in total against about €150bn in the EU, investing around six times more than their European counterparts [2]. The UK is now the third-largest venture market in the world and the largest in Europe, accounting for around 6% of global investment [3], but the two are not the same order of magnitude, and the gap widens as companies scale.

That gap is felt most acutely beyond Series A. The UK has genuine early-stage strength, helped by SEIS, EIS and government programmes, and UK startups raised around $17.3bn in the first three quarters of 2025 [4]. The difficulty is the transition to scale: US median deal value rose to around $115m, up from $63m, as capital concentrated in fewer, larger rounds, and seven of the world's top ten tech hubs sit in the US [5]. For a founder who needs a large Series B or a US enterprise customer base, the pull west is structural, not fashion.

US capital is not just bigger. It is a different investment culture, with deeper funds, higher risk appetite, and more exit routes, and it comes attached to a set of structural expectations UK founders meet at the worst possible moment: mid-fundraise, with a diligence clock running.

There is a macro-political dimension too. US policy, US tax law and US investor norms set the weather that UK high-growth companies operate in, and when UK companies do raise US money, the returns and often the eventual headquarters can migrate across the Atlantic. That is the backdrop. The practical question for a founder is narrower: does taking US money actually require a US company?

Do you actually need a Delaware company to take US money?

For early US angel and seed cheques, usually not. A US-resident individual can lawfully subscribe for shares in a UK company, and nothing in UK or US law forces a flip or a US entity to admit a minority US subscription. This is the single most common misconception in UK-to-US conversations: founders assume the Delaware C-corp is the price of entry, when for the first cheques it generally is not.

The assumption is understandable, because it is often true at the stage founders eventually reach. Most US venture funds are built to invest in Delaware C-corps, some are contractually required to, and accelerators such as Y Combinator make it a condition. So the flip is real, but it is a later-round question, triggered by a priced, US-led institutional round, not a precondition of the first angel who wants in.

The distinction matters because the two situations have opposite cost profiles. Admitting an angel to a UK Ltd is administratively light. Flipping the group to a Delaware parent is expensive, invites tax complexity on both sides, and is very hard to reverse.

What do US angels, funds, family offices and PE actually want, and why?

Different pools of US capital want overlapping but not identical things. The common thread is a domestic C-corp, and the reasons are mostly about tax treatment and familiar paper.

• US angel investors strongly prefer Delaware C-corps because of QSBS. If they invest in original-issue stock of a qualifying US C-corporation and hold long enough, a large slice of their gain can be excluded from US federal tax. No UK structure can match that for a US taxpayer, which is why angels lean hard towards US entities.
• US venture capital wants Delaware for the practical reasons above (lawyers' familiarity, NVCA standard documents, faster diligence) and for QSBS eligibility, reduced foreign-corporation reporting, and to avoid Subpart F and GILTI-type inclusions. Funds frequently require a foreign-incorporated startup to flip precisely to clean these issues up.
• US private equity, arriving later, prices clean domestic structures most efficiently and is least tolerant of foreign-entity complexity, carved-out territorial rights, or unevidenced reliefs. By the growth-equity stage a US parent is often simply assumed.
• US family offices are heterogeneous. Some invest like angels or funds and share the same C-corp/QSBS preference; but a family office also carries a web of cross-border tax sensitivities (CFC, PFIC, GILTI, FATCA/FBAR reporting) that make a foreign corporation on the books unattractive to hold.

A word on donor-advised funds (DAFs). A DAF is a US charitable-giving vehicle, not a startup-investing structure. It is relevant to US investors as a way to give away appreciated stock tax-efficiently (including, potentially, QSBS-eligible shares after an exit), and it shapes how wealthy US investors think about their eventual gains, but it is not something a UK founder structures the company around. Treat it as part of the investor's personal estate and philanthropy picture, not part of your cap table.

The unifying logic across all four pools: US capital wants a structure where the US tax code works in the investor's favour and the US reporting burden is minimal. A UK company delivers neither by default, which is what the flip is really about.

What is QSBS, and why can't a UK company offer it?

QSBS (IRC §1202) is the exemption US investors and their advisers prize most, and it is only ever available on original-issue stock of a US domestic C-corporation. A UK company cannot issue it, full stop. That single fact sits underneath most of the pressure to flip.

The 2025 One Big Beautiful Bill Act made QSBS more attractive, not less. For stock acquired after 4 July 2025, the exclusion is tiered (50% at three years, 75% at four, 100% at five), the per-issuer cap rose to the greater of $15m or 10x basis, and the company gross-asset ceiling rose to $75m, both indexed after 2026 [6]. Stock acquired on or before that date keeps the old five-year / $50m / $10m rules.

Two traps founders and investor materials must never fall into:

• A flip does not upgrade existing shares. Shares received in a share-for-share flip are acquired in exchange for stock, which fails the QSBS consideration and original-issue tests. The §1202 carryover preserves QSBS only where the exchanged stock was already QSBS, and UK shares never are. The rules preserve QSBS; they do not create it [8].
• Only new money into the US C-corp qualifies. After a flip, the realistic QSBS population is fresh cash subscribed into the Delaware entity, with its own holding-period clock starting then. Everything exchanged in the flip stays, in substance, where it was.

By contrast, the nearest UK equivalent, Business Asset Disposal Relief, is capped at £1m of lifetime gains, is available to employees of the company rather than outside investors, and is simply not comparable firepower for a US angel [7]. This asymmetry is why QSBS, not corporate tax rates, is the real engine behind US-investor structural preference.

What risks do US investors face holding shares in a UK company?

The costs of a UK-company holding fall almost entirely on the US investor personally, not on the company, which is precisely why they are manageable by disclosure and covenant rather than by restructuring.

• PFIC (Passive Foreign Investment Company). A foreign corporation is a PFIC if 75%+ of its income, or 50%+ of its assets by value, is passive; managing this exposure is one of the stated reasons US funds require foreign-incorporated startups to invert into the US [9]. Cash is a passive asset, so a fresh raise landing on a small balance sheet can trip the asset test in the round year. The defences are that operating-software revenue is active, and that the asset test for a private company is applied by value (capturing self-created IP and goodwill the accounts understate). If PFIC status does arise, a QEF election converts punitive default treatment into current inclusion, but it needs an annual PFIC information statement from the company. A modest annual information covenant, not a structural change, is the right answer.
• Form 5471. A US holder crossing 10% of the company (by vote or value) picks up a Form 5471 filing obligation, with meaningful penalties. Sizing a subscription to sit below 10% of issued shares keeps this away entirely, so watch the difference between fully-diluted and issued percentages when pricing the cheque.
• FBAR and Form 8938. These are the US investor's personal foreign-asset reports, not company filings, but the penalties for missing them are severe, so they belong on the table at the outset.

None of this requires the company to file anything with the IRS. On a direct UK-company subscription there is no US registration and no US return for the company; the UK also imposes no withholding tax on dividends and does not tax a non-resident's gain on selling the shares. That clean, zero-withholding profile is a genuine positive of subscribing directly, provided the investor's personal reporting is handled properly.

What do US CPAs think, and why do they want a "blank slate"?

US CPAs tend to advise UK companies to start from a clean domestic structure, and from a purely US-tax standpoint that advice is rational. A Delaware C-corp with US-issued stock gives them QSBS eligibility, no PFIC or Subpart F analysis, no Form 5471 overhead, and financial statements on a US GAAP basis they can work with directly. Faced with a foreign corporation on the cap table, the instinct is to simplify it away, hence the preference for a blank slate: incorporate in Delaware, issue fresh US stock, and treat the UK entity as a subsidiary or wind it into the structure.

The limitation is not that the advice is wrong; it is that it is usually one-sided. A US CPA is not engaged to protect UK SEIS and EIS relief, EMI options, R&D claims, Patent Box, or a founder's BADR profile, and a flip driven by US-tax logic alone can quietly damage all of them. A share-for-share flip can strand the UK loss pool beneath a US parent, strain EIS conditions, expose founders to US estate tax on US-situs stock, and, if EMI options are promised but not yet granted, lose their protected status entirely. These are UK-side consequences a US-only adviser has no reason to flag.

The failure mode is not bad advice on either side. It is sequential advice: a US CPA optimises the US picture, a UK adviser optimises the UK picture, and no one owns the interaction. The flip decision lives exactly in that interaction.

What should a UK founder do?

Take the money you can take cleanly now, and hold the flip as a priced option rather than a reflex.

• For early angel and seed money, stay UK. Admit US individuals directly into the UK company on EIS-clean terms where relief matters to your other investors. Add a PFIC information covenant and size subscriptions against issued shares to keep US holders below the 10% Form 5471 line where you can.
• Grant committed EMI options before any structural step. This is the single most time-sensitive action, because EMI granted while the company is independent survives a later reorganisation, and EMI merely promised does not.
• Keep the cap table clean and evidenced. Reconcile the register, confirm which SAFEs and ASAs have converted, and evidence the SEIS/EIS history. This is the diligence critical path for any round, US or UK.
• Treat the flip as a US-lead trigger, not a readiness exercise. A term sheet from a US lead conditioning investment on a Delaware parent is both the commercial justification and the strongest evidence for the UK clearances a flip needs. Flipping speculatively "to look ready" is weaker on every axis, and the flip is close to a one-way door once done.

The disciplined position is to be investable to US capital without prematurely paying the flip's cost: UK reliefs preserved, cap table clean, and the Delaware option held, exercisable the moment a priced round actually prices it.

For a founder weighing a specific round, the Structure Review works through exactly this trade-off on your own facts, and the free Exposure Score is a good first pass on whether a US structural step is anywhere near being required.

Sources

Market and capital-market figures, and the QSBS, PFIC and BADR points marked in the text, draw on the following. Statute-level specifics (QSBS mechanics under §1202 as amended, PFIC tests, the Form 5471 threshold) should be confirmed against enacted text and current HMRC/IRS guidance before they are relied on.

1. Foothold America, Delaware C Corp vs UK Ltd: A Guide for US Fundraising (2026), citing Crunchbase 2025 data (US companies raised about $274bn, ~64% of global venture funding). https://www.footholdamerica.com/blog/delaware-c-corp-vs-uk-ltd-a-guide-for-us-fundraising
2. European Central Bank, Exploring the investor landscape for venture capital (May 2026): US VC total fund size ~€930bn vs ~€150bn in the EU, investing ~6x more. https://www.ecb.europa.eu/press/fie/box/html/ecb.fiebox202605_04.en.html
3. British Business Bank, Small Business Equity Tracker / UK now the third largest venture capital market in the world: UK ~6% of global VC investment, largest in Europe. https://www.british-business-bank.co.uk/news-and-events/news/uk-now-third-largest-venture-capital-market-world-biggest-increase-share-global-investment
4. Frazier & Deeter, Navigating US Investor Expectations in 2026 (Jan 2026): UK startups raised ~$17.3bn in the first three quarters of 2025. https://www.frazierdeeter.co.uk/insights/article/navigating-us-investor-expectations-in-2026-what-uk-founders-need-to-know/
5. Business Weekly / Frazier & Deeter, Navigating US investor expectations in 2026 (Dec 2025): US median deal value ~$115m (up from ~$63m); seven of the world's top ten tech hubs in the US. https://www.businessweekly.co.uk/posts/navigating-us-investor-expectations-in-2026-what-uk-founders-need-to-know
6. Foothold America (2026), citing the AICPA Tax Adviser: post-4-July-2025 QSBS tiered exclusion (50/75/100% at 3/4/5 years), per-shareholder cap raised to $15m or 10x cost, gross-asset ceiling raised to $75m. https://www.footholdamerica.com/blog/delaware-c-corp-vs-uk-ltd-a-guide-for-us-fundraising
7. Frazier & Deeter, Decoding the Delaware Flip (May 2025): QSBS vs UK BADR comparison (BADR capped at £1m, employees only). https://www.frazierdeeter.co.uk/insights/article/decoding-the-delaware-flip-an-expansion-guide-for-uk-startups/
8. Wilson Sonsini, Key UK Tax Implications of the Delaware Flip (2025): shares issued by the US holding company on a flip do not generally qualify for QSBS. https://www.wsgr.com/en/insights/key-uk-tax-implications-of-the-delaware-flip.html · See also Hanson Bridgett, Tax Planning for Foreign Founders (Oct 2025): the flip structure will almost never allow QSBS on the reorganisation shares. https://www.hansonbridgett.com/publication/250306-7000-united-states-tax-planning-foreign-founders
9. Fenwick, PFIC: What U.S. Investment Funds Should be Particularly Aware of: PFIC definition and the reasons funds require foreign-incorporated startups to invert (QSBS eligibility, reduced US reporting, avoiding Subpart F/GILTI). https://www.fenwick.com/insights/publications/pfic-what-u-s-investment-funds-should-be-particularly-aware-of-and-newly-proposed-regulations